Denmark · Who invested in Orphazyme?
Orphazyme's investors include Sunstone Life Science Ventures, Novo Holdings A/S, Aescap, Idinvest Partners and Kurma Life Science Partners.
20112012201320142015
?Seed$20MSeries A$24MSeries BDenmark · Series B startup
Who invested in Orphazyme
3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$44Mraised across 3 rounds since 2011, from 3 sources
$20MSeries A$24MSeries B
- Latest round
- Series B, $24MJan 2015
- Step-upi
- 1.2×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed Feb 2011
- Biggest round
- $24M Series B · Jan 2015
- Usual gap between rounds
- 3.3 years the median of 2
The rounds
- Jan 2015Series B$24M2 new2 returning
From a historical funding record
- Sept 2011Series A$20M1 new2 returning
Reported by fiercebiotech.com
- Feb 2011
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Seed2011Series A2011Series B2015
Sunstone Life Science VenturesNovo Holdings A/S
Aescap
Idinvest PartnersKurma Life Science Partners
Sunstone Life Science VenturesNovo Holdings A/SAescapIdinvest PartnersKurma Life Science PartnersEveryone who backed them
Novo Holdings A/SGrowth equity2rounds
Kurma Life Science PartnersGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Orphazyme
How much has Orphazyme raised?
Orphazyme has raised $44M across 3 rounds since 2011. One round did not disclose an amount, so the total is a floor.
When did Orphazyme last raise?
Orphazyme's most recent round was a Series B of $24M in Jan 2015.
What was Orphazyme's biggest round?
Its most recent round, $24M in Jan 2015, is also its largest on record.
Who backed Orphazyme first?
Orphazyme's first round on record, in Feb 2011, was backed by Novo Holdings A/S and Sunstone Life Science Ventures.
What stage is Orphazyme at?
Orphazyme's latest named round is a Series B, in Jan 2015.
Where is Orphazyme based?
Orphazyme is based in Denmark.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.